Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab.

about

and Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients

P2860

Q58761037-F1A84190-1675-4A1E-9BF8-52C757D3472F

P2860

Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab.

Item

http://www.wikidata.org/entity/Q47150792

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@en

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@nl

type

Item

label

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@en

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@nl

prefLabel

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@en

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@nl

P1476

Role of VEGFA gene polymorphis ...... who treated with bevacizumab.

@en

P2093

Bo Yu

http://www.w3.org/2001/XMLSchema#string

Cailing Chen

http://www.w3.org/2001/XMLSchema#string

Feng Li

http://www.w3.org/2001/XMLSchema#string

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Qiang Yuan

http://www.w3.org/2001/XMLSchema#string

Wei Cui

http://www.w3.org/2001/XMLSchema#string

P2860

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Genetic variants of EGF and VEGF predict prognosis of patients with advanced esophageal squamous cell carcinoma.

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer

C936T polymorphism of the VEGF gene in relation to the risk and the clinical and biological characteristics of sporadic colorectal adenocarcinoma

Colorectal cancer statistics, 2014.

Prospective validation of candidate SNPs of VEGF/VEGFR pathway in metastatic colorectal cancer patients treated with first-line FOLFIRI plus bevacizumab

Role of genetic polymorphisms in tumour angiogenesis

Clinical genotyping and efficacy outcomes: exploratory biomarker data from the phase II ABIGAIL study of first-line bevacizumab plus chemotherapy in non-squamous non-small-cell lung cancer.

Alternative splicing of VEGFA, APP and NUMB genes in colorectal cancer

Cellular abnormalities of blood vessels as targets in cancer.

P304

105472-105478

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.22295

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-11-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29285265

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

bevacizumab

P932

5739652

http://www.w3.org/2001/XMLSchema#string

Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab.

about

P2860

P2860

Role of VEGFA gene polymorphisms in colorectal cancer patients who treated with bevacizumab.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P921

P932